Wash- ington, DC: National Academies Press; 2011. 4. Jacobs AK, Kushner FG, Ettinger SM, et al. ACCF/AHA clinical prac- tice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:268 310. 5. Jacobs AK, Anderson JL, Halperin JL. The evolution and future of ACC/ AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:1208 17. 6. Anderson JL, Heidenreich PA, Barnett PG, et al. ACC/AHA state- ment on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Perfor- mance Measures and Task Force on Practice Guidelines. Circula- tion. 2014;129:2329 45. 7. Arnett DK, Goodman RA, Halperin JL, et al. AHA/ACC/HHS strate- gies to enhance application of clinical practice guidelines in pa- tients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and U.S. Department of Health and Human Services. Circulation. 2014;130:1662 7. 8. Halperin JL, Levine GN, Al-Khatib SM, et al. Further evolution of the ACC/AHA clinical practice guideline recommendation classi- fication system: a report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guide- lines. Circulation. 2016;133:1426 28. 9. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med. 1987;316:1429 35. 10. Effect of enalapril on survival in patients with reduced left ven- tricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med. 1991;325:293 302. 11. Packer M, Poole-Wilson PA, Armstrong PW, et al. 